Shanghai Hutchison Whampoa (China) Co., Ltd. and Shanghai Medicinal Materials Co., Ltd. were established in August, 20001year. They are the first Chinese medicine joint ventures in Shanghai with a total investment of 220 million yuan. The original Shanghai No.1 Chinese Medicine Factory and the trademark "Shangyao" were transferred to the joint venture company.
Shanghai Medicinal Materials Company is a wholly-owned subsidiary of Shanghai Pharmaceutical Group Co., Ltd., which was established in 1955. Up to now, it has developed into a large-scale Chinese medicine enterprise integrating scientific research, production and trade, with annual sales exceeding 3 billion yuan.
Shanghai No.1 Chinese Medicine Factory was established in 1958, which was formed by the merger of four century-old pharmacies in Shanghai: Lei, Hu Qingyu, Tong and Cai Tongde. Is a traditional Chinese medicine time-honored enterprise with excellent tradition, rich experience, comprehensive dosage forms and advanced technology.
Hutchison Whampoa Group, a multinational comprehensive enterprise under Mr. Li Ka-shing, is one of the top 500 enterprises in the world. It operates many businesses in 42 countries around the world, including health care, and is one of the most important investors in Chinese mainland. Hutchison Whampoa is committed to the globalization of Chinese medicine. Since 2000, it has established many medical and health care businesses in China and Europe, including Shanghai Hutchison Pharmaceutical.
Shanghai Hutchison Pharmaceutical Co., Ltd. relies on Hutchison Whampoa's abundant capital and management strength to carry forward and expand its traditional advantages, and has developed into a well-known Chinese medicine manufacturer with 70 varieties of pills, tablets and injections, registered trademark "Shangyao" brand, musk Baoxin Pills, Tannin Tablets and Shengmai Injection, and has made continuous efforts to promote the modernization of Chinese medicine.